Toggle Health Problems and D

14.7 X more likely to die of COVID-19 if less than 12 ng of Vitamin D (185 Germans) – Sept 10, 2020

Vitamin D Deficiency and Outcome of COVID-19 Patients

Nutrients 2020, 12(9), 2757; https://doi.org/10.3390/nu12092757
by Aleksandar Radujkovic 1,Theresa Hippchen 2,Shilpa Tiwari-Heckler 2,Saida Dreher 2,Monica Boxberger 2 andUta Merle 2,*OrcID
1 Department of Internal Medicine V, University of Heidelberg, 69121 Heidelberg, Germany
2 Department of Internal Medicine IV, University of Heidelberg, 69121 Heidelberg, Germany


COVID-19 treated by Vitamin D - studies, reports, videos
As of Jan 22, 2022, the VitaminDWiki COVID page had:  19 trial results,   37 meta-analyses and reviews,   Mortality studies   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   26 risk factors are ALL associated with low Vit D,   Recent Virus pages   Fight COVID-19 with 50K Vit D weekly   Vaccines   Take lots of Vitamin D at first signs of COVID   123 COVID Clinical Trials using Vitamin D (1/2023)   Cost to prevent a COVID death: 11 dollars of Vitamin D - Nov 2022
5 most-recently changed Virus entries

Items in both categories Virus and Mortality are listed here:

 Download the PDF from VitaminDWiki

Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses an enormous challenge to health care systems throughout the world. Without causal treatment, identification of modifiable prognostic factors may help to improve outcomes. To explore possible associations of vitamin D (VitD) status with disease severity and survival, we studied 185 patients diagnosed with coronavirus disease 2019 (COVID-19) and treated at our center. VitD status at first presentation was assessed retrospectively using accredited laboratory methods. VitD deficiency was defined as serum total 25-hydroxyvitamin D level < 12 ng/mL (<30 nM). Primary endpoint was severe course of disease (i.e., need for invasive mechanical ventilation and/or death, IMV/D). Within a median observation period of 66 days (range 2–92), 23 patients required IMV. A total of 28 patients had IMV/D, including 16 deaths. Ninety-three (50%) patients required hospitalization (inpatient subgroup). A total of 41 (22%) patients were VitD deficient.
When adjusted for age, gender, and comorbidities, VitD deficiency was associated with higher risk of IMV/D and death (HR 6.12, 95% CI 2.79–13.42, p < 0.001 and HR 14.73, 95% CI 4.16–52.19, p < 0.001, respectively). Similar correlations were observed in the inpatient subgroup. Our study demonstrates an association between VitD deficiency and severity/mortality of COVID-19, highlighting the need for interventional studies on VitD supplementation in SARS-CoV-2 infected individuals.

Created by admin. Last Modification: Sunday January 10, 2021 04:28:46 GMT-0000 by admin. (Version 5)

Attached files

ID Name Comment Uploaded Size Downloads
14292 Vitamin D Deficiency and Outcome of COVID-19 Patients_compressed.pdf PDF 2020 admin 10 Sep, 2020 14:23 341.09 Kb 433
14291 Survival.jpg admin 10 Sep, 2020 14:21 31.79 Kb 14288